Stereotactic Ablative Radiation for Oligoprogressive Cancers: Results of the Randomized Phase 2 STOP Trial.

Saved in:
Bibliographic Details
Title: Stereotactic Ablative Radiation for Oligoprogressive Cancers: Results of the Randomized Phase 2 STOP Trial.
Authors: Schellenberg D; Department of Radiation Oncology, BC Cancer - Surrey, Surrey, British Columbia, Canada. Electronic address: dschellenberg@bccancer.bc.ca., Gabos Z; University of Alberta, Edmonton, Alberta, Canada., Duimering A; University of Alberta, Edmonton, Alberta, Canada., Debenham B; University of Alberta, Edmonton, Alberta, Canada., Fairchild A; University of Alberta, Edmonton, Alberta, Canada., Huang F; University of Alberta, Edmonton, Alberta, Canada., Rowe LS; University of Alberta, Edmonton, Alberta, Canada., Severin D; University of Alberta, Edmonton, Alberta, Canada., Giuliani ME; Department of Radiation Oncology, University of Toronto, Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Bezjak A; Department of Radiation Oncology, University of Toronto, Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Lok BH; Department of Radiation Oncology, University of Toronto, Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Raman S; Department of Radiation Oncology, University of Toronto, Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Chung P; Department of Radiation Oncology, University of Toronto, Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Zhao Y; Department of Radiation Oncology, BC Cancer - Surrey, Surrey, British Columbia, Canada., Ho CK; Department of Radiation Oncology, BC Cancer - Surrey, Surrey, British Columbia, Canada., Lock M; Department of Radiation Oncology, London Health Sciences Centre, London, Ontario, Canada., Louie AV; Department of Radiation Oncology, University of Toronto, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada., Lefresne S; Department of Radiation Oncology, BC Cancer - Vancouver Centre, Vancouver, British Columbia, Canada., Carolan H; Department of Radiation Oncology, BC Cancer - Vancouver Centre, Vancouver, British Columbia, Canada., Liu M; Department of Radiation Oncology, BC Cancer - Vancouver Centre, Vancouver, British Columbia, Canada., Yau V; Department of Radiation Oncology, BC Cancer - Centre for the North, Prince George, British Columbia, Canada., Ye A; Department of Radiation Oncology, BC Cancer - Centre for the North, Prince George, British Columbia, Canada., Olson RA; Department of Radiation Oncology, BC Cancer - Centre for the North, Prince George, British Columbia, Canada., Mou B; Department of Radiation Oncology, BC Cancer - Kelowna, Kelowna, British Columbia, Canada., Mohamed IG; Department of Radiation Oncology, BC Cancer - Kelowna, Kelowna, British Columbia, Canada., Petrik DW; Department of Radiation Oncology, BC Cancer - Kelowna, Kelowna, British Columbia, Canada., Dosani M; Department of Radiation Oncology, BC Cancer - Victoria, Victoria, British Columbia, Canada., Pai H; Department of Radiation Oncology, BC Cancer - Victoria, Victoria, British Columbia, Canada., Valev B; Department of Radiation Oncology, BC Cancer - Victoria, Victoria, British Columbia, Canada., Gaede S; Department of Medical Physics, Western University, London, Ontario, Canada., Warner A; Department of Radiation Oncology, London Health Sciences Centre, London, Ontario, Canada., Palma DA; Department of Radiation Oncology, London Health Sciences Centre, London, Ontario, Canada.
Source: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2025 Jan 01; Vol. 121 (1), pp. 28-38. Date of Electronic Publication: 2024 Aug 19.
Publication Type: Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 7603616 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-355X (Electronic) Linking ISSN: 03603016 NLM ISO Abbreviation: Int J Radiat Oncol Biol Phys Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1879-355X
DOI:10.1016/j.ijrobp.2024.08.031